Cutting down R&D inefficiency and restoring the trust of investors and consumers are key to curing the industry’s ills.
Business Administration, Management, and Operations | Medicinal Chemistry and Pharmaceutics | Technology and Innovation
Copyright Owner and Holder
Copyright © Singapore Management University 2014
Licece/Creative Commons Licence
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.
Singapore Management University.
Big Pharma is Hurt. (2014). Perspectives@SMU.
Available at: http://ink.library.smu.edu.sg/pers/85